|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Employee Stock Option (right to buy) | $ 102.01 | 03/27/2019 | M | 2,720 | (19) | 02/03/2024 | Common Stock | 2,720 | $ 0 | 0 | D | ||||
Employee Stock Option (right to buy) | $ 159.14 | 03/27/2019 | M | 934 | (20) | 05/01/2025 | Common Stock | 934 | $ 0 | 623 | D | ||||
Employee Stock Option (right to buy) | $ 175.2 | 03/27/2019 | M | 1,467 | (21) | 11/02/2025 | Common Stock | 1,467 | $ 0 | 977 | D | ||||
Employee Stock Option (right to buy) | $ 152.28 | 03/27/2019 | M | 963 | (22) | 11/01/2026 | Common Stock | 963 | $ 0 | 2,890 | D | ||||
Employee Stock Option (right to buy) | $ 166.18 | 03/27/2019 | M | 2,324 | (23) | 06/30/2027 | Common Stock | 2,324 | $ 0 | 9,293 | D | ||||
Employee Stock Option (right to buy) | $ 189.98 | 03/27/2019 | M | 1,038 | (24) | 11/02/2027 | Common Stock | 1,038 | $ 0 | 4,141 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Robie Robert J. C/O FACTSET RESEARCH SYSTEMS INC. 601 MERRITT 7 NORWALK, CT 06851 |
EVP, Head of Trading&Analytics |
/s/ Robert J. Robie | 03/29/2019 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 800, the per share sales prices ranged from $239.14 to $240.13. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(2) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 700, the per share sales prices ranged from $240.32 to $241.30. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(3) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 920, the per share sales prices ranged from $241.52 to $242.49. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(4) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 300, the per share sales prices ranged from $242.67 to $243.47. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(5) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 934, the per share sales prices ranged from $243.00 to $243.13. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(6) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 504, the per share sales prices ranged from $239.15 to $239.87. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(7) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 300, the per share sales prices ranged from $240.32 to $241.30. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(8) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 500, the per share sales prices ranged from $241.42 to $242.38. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(9) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 163, the per share sales prices ranged from $242.49 to $243.47. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(10) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 600, the per share sales prices ranged from $239.14 to $239.87. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(11) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 510, the per share sales prices ranged from $240.14 to $240.47. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(12) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 700, the per share sales prices ranged from $241.24 to $242.23. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(13) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 414, the per share sales prices ranged from $242.25 to $242.76. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(14) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 438, the per share sales prices ranged from $240.44 to $241.17. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(15) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 600, the per share sales prices ranged from $242.44 to $243.47. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(16) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 512, the per share sales prices ranged from $239.17 to $240.11. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(17) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 301, the per share sales prices ranged from $240.28 to $240.99. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(18) | Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 200, the per share sales prices ranged from $241.48 to $242.38. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4. |
(19) | Options granted on February 3, 2014 vest over a 5 year period with 60% exercisable three years after the grant date and the remaining 40% exercisable five years after the grant date. |
(20) | Options granted on May 1, 2015 vest over a 5 year period with 60% exercisable three years after the grant date and the remaining 40% exercisable five years after the grant date. |
(21) | Options granted on November 2, 2015 vest 20% annually on the anniversary date of the grant and are fully vested after five years. |
(22) | Options granted on November 1, 2016 vest 20% annually on the anniversary date of the grant and are fully vested after five years. |
(23) | Options granted on June 30, 2017 vest 20% annually on the anniversary date of the grant and are fully vested after five years. |
(24) | Options granted on November 2, 2017 vest 20% annually on the anniversary date of the grant and are fully vested after five years. |